Investor Ideas Podcast #578, Interview with CEO of Albert Labs
Written by Taylor Van Zant,
In today’ s podcast Investorideas interviews Dr. Michael Raymont, CEO of Albert Labs, a laboratory based, clinical research and drug development enterprise, focused on improving patient access to psychedelic assisted therapies through accelerated regulatory approval pathways, where we discussed the companies unique approach through Real World Evidence studies, the psychedelic landscape in the EU and UK as well as expectations around how the medical side of psychedelics will continue to develop.
Dr. Raymont’ s career has spanned leadership roles in venture capital, agricultural and healthcare investment, tech company leadership and senior Government service, where he ran the National Research Council (NRC), Canada’ s largest R&D organization. With a background in both science and business, Dr. Raymont has advised corporations and governments, worked extensively internationally, and has sat on the boards of over 50 public and private companies.